Footprint Pharma ApS: Financial statements 2020
CVR: 37165174
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Footprint Pharma ApS (CVR 37165174) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -1,263 and a net result of DKK 5,851 compared with DKK -59,461 the year before. Equity in the 2020 report amounted to DKK 466,267. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -1,263
- Profit/Loss
- DKK 5,851
- Equity
- DKK 466,267
- Total Assets
- DKK 466,267
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | -1 t. | 6 t. | 466 t. | - |
| 2019 | 0 | -59 t. | -59 t. | 460 t. | - |
| 2018 | 0 | -368 t. | -368 t. | 532 t. | - |
| 2017 | 0 | -144 t. | -144 t. | 760 t. | - |
Official annual report
How creditworthy is Footprint Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Footprint Pharma ApS has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK -59,461.
About Footprint Pharma ApS
Footprint Pharma ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2015. The company has been dissolved on 26 November 2021. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named vHL Group ApS. In 2020, the company reported a gross profit of DKK -1,263 and a net result of DKK 5,851 compared with DKK -59,461 the year before. Equity in the 2020 report amounted to DKK 466,267.